Take Solutions Limited has announced its strategic entry into India's longevity and anti-aging market through a Regulation 30 filing, marking a significant expansion into the healthcare and wellness sector.

Regulatory Filing and Market Entry

The company filed its announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, outlining plans to disrupt the Indian longevity and anti-aging solutions market. The press release details the company's strategic focus on developing science-backed nutraceuticals, biohacking solutions, and technology-enabled preventive healthcare offerings.

Market Opportunity and Size

The global longevity market presents substantial growth opportunities, with significant expansion projected across multiple segments. The company aims to capitalize on India's growing health-conscious consumer base through its established expertise in clinical research and regulatory processes.

Business Strategy and Technology Integration

Take Solutions' entry strategy centers on a dual model combining product innovation with technology-enabled health solutions. The company plans to develop science-backed nutraceuticals, biohacking-focused products, and predictive digital tools for tracking metabolic health, sleep, cognition, and biological aging.

"Through this initiative, we aim to build a diversified revenue mix across consumer products, services, and digital platforms, while leveraging our core strengths in healthcare and regulatory execution to deliver solutions that are both scalable and clinically credible," said Mr. Parmeshvar Dhangare, Director of Take Solutions Limited.

Market Positioning and Competitive Advantage

The company believes its existing capabilities in healthcare operations, regulatory support, and life sciences can be extended to accelerate development, validation, and commercialization in the longevity market. This approach aims to create differentiated offerings in an underpenetrated market with strong repeat-purchase potential and attractive margin profiles.

Take Solutions Limited has submitted its quarterly compliance certificate to stock exchanges, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations 2018. The filing demonstrates the company's adherence to mandatory compliance procedures for the quarter ended 31st March 2026.

Regulatory Filing Details

The compliance certificate was filed on 13th April 2026 with both major Indian stock exchanges. The submission was made simultaneously to BSE Limited and National Stock Exchange of India Limited, ensuring comprehensive regulatory compliance across trading platforms.

Registrar Confirmation

MUFG Intime India Private Limited, serving as the company's Registrar and Transfer Agent, issued the compliance confirmation on 3rd April 2026. The registrar confirmed that all securities received from depository participants for dematerialisation during Q4FY26 were properly processed within prescribed timelines.

Key compliance confirmations include:

• Securities received for dematerialisation were confirmed or rejected to depositories
• Security certificates were mutilated and cancelled after due verification
• Depository names were substituted in the register of members as registered owners
• All processes completed within regulatory timelines

Corporate Governance

The filing was signed by Director Parmeshvar Dhangare using digital signature technology, reflecting modern corporate governance practices. The systematic submission demonstrates Take Solutions' commitment to maintaining regulatory compliance and transparency with market authorities.

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, continues to serve as the company's registrar, ensuring proper maintenance of shareholder records and compliance with depositories regulations. The registrar's confirmation was signed by Ashok Shetty, Sr. Vice President-Corporate Registry, providing institutional backing for the compliance certification.